Canopy Growth Corp (WEED)

Currency in CAD
0.630
-0.060(-8.70%)
Closed·
Trading near 52-week Low
WEED is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.6200.680
52 wk Range
0.6203.280
Key Statistics
Prev. Close
0.69
Open
0.66
Day's Range
0.62-0.68
52 wk Range
0.62-3.28
Volume
878.08K
Average Volume (3m)
709.76K
1-Year Change
-59.6154%
Book Value / Share
1.54
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WEED Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.928
Upside
+206.08%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Canopy Growth Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
6 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.928
(+206.08% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Bernstein SocGen Group
Hold1.70+169.84%2.50MaintainJun 25, 2026
Canaccord
Buy2.00+217.46%-New CoverageMar 27, 2026
ATB Capital Markets
Hold1.40+122.22%-UpgradeMar 17, 2026
Bernstein SocGen Group
Hold2.50+296.83%5.30MaintainJan 14, 2026

Canopy Growth Corp Earnings Call Summary for Q1/2027

  • Canopy Growth reported Q1 fiscal 2027 adjusted EPS loss of 5.8 cents, beating estimates of 7.76 cents; revenue reached $82.2M, slightly below forecast.
  • Adjusted gross margin improved to 31% from 25% YoY; adjusted EBITDA loss narrowed 59% to CAD 3.2M, marking first quarter with growth across all segments.
  • Net revenue climbed 13% YoY to CAD 81.2M, with Canadian medical cannabis up 22%, adult-use up 10%, and Storz & Bickel vaporizers up 6%.
  • Management reaffirmed guidance for positive adjusted EBITDA in fiscal 2027, targeting mid-30% gross margins near-term with long-term goal approaching 50%.
  • Company holds CAD 337M in cash with 3.34 current ratio; executing CAD 8M in MTL synergies with upside potential beyond original CAD 10M target.
Last Updated: 2026-08-07, 11:02 a/m
Read Full Transcript

Earnings

Latest Release
Nov 06, 2026
EPS / Forecast
-0.10 / -0.04
Revenue / Forecast
81.37M / 82.19M
EPS Revisions
Last 90 days

WEED Income Statement

Compare WEED to Peers and Sector

Metrics to compare
WEED
Peers
Sector
Relationship
P/E Ratio
−1.0x−1.9x−0.2x
PEG Ratio
−0.02−0.010.00
Price/Book
0.4x0.4x2.6x
Price / LTM Sales
0.9x0.5x2.6x
Upside (Analyst Target)
206.1%167.6%77.0%
Fair Value Upside
Unlock34.9%13.7%Unlock

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R’belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Employees
1128
Market
Canada

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
15.47M3.65%9.75M
Other Institutional Investors
10.62M2.51%6.69M
Public Companies & Retail Investors
397.26M93.84%250.27M
Total
423.35M100.00%266.71M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Amplify ETF Trust - Amplify Alternative Harvest ETF2.12%8,984,1005,660
Tidal Investments LLC2.04%8,617,5365,429

People Also Watch

424.39
AMD
-13.25%
88.91
ANT
-8.50%
143.49
PLTR
-6.63%
5.990
ACB
-2.44%
125.53
NVDA
-14.01%

FAQ

What Is the Canopy Growth (WEED) Stock Price Today?

The Canopy Growth stock price today is 0.630 CAD.

What Stock Exchange Does Canopy Growth Trade On?

Canopy Growth is listed and trades on the Toronto Stock Exchange.

What Is the Stock Symbol for Canopy Growth?

The stock symbol for Canopy Growth is "WEED."

What Is the Canopy Growth Market Cap?

As of today, Canopy Growth market cap is 266.710M CAD.

What Is Canopy Growth's Earnings Per Share (TTM)?

The Canopy Growth EPS (TTM) is -0.68.

When Is the Next Canopy Growth Earnings Date?

Canopy Growth will release its next earnings report on Feb 05, 2027.

From a Technical Analysis Perspective, Is WEED a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Canopy Growth Stock Split?

Canopy Growth has split 2 times.

How Many Employees Does Canopy Growth Have?

Canopy Growth has 1128 employees.

What is the current trading status of Canopy Growth (WEED)?

As of Nov 22, 2026, Canopy Growth (WEED) is trading at a price of 0.630 CAD, with a previous close of 0.690 CAD. The stock has fluctuated within a day range of 0.620 CAD to 0.680 CAD, while its 52-week range spans from 0.620 CAD to 3.280 CAD.

What Is Canopy Growth (WEED) Price Target According to Analysts?

The average 12-month price target for Canopy Growth is 1.928 CAD, with a high estimate of 5 CAD and a low estimate of 0.9 CAD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +206.08% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.